<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02295293</url>
  </required_header>
  <id_info>
    <org_study_id>CT-P-92-5581</org_study_id>
    <nct_id>NCT02295293</nct_id>
  </id_info>
  <brief_title>The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia</brief_title>
  <acronym>SomaghLipid</acronym>
  <official_title>The Effects of Rhus Coriaria L. (Rhus or Somagh) on Serum Lipid Levels of Patients With Hyperlipidemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary heart disease and stroke are two main causes of human deaths and is directly related
      to increased levels of plasma lipids.High total cholesterol and low high density lipoprotein
      cholesterol concentrations are often associated with endothelium dysfunction and
      inflammation, which can be followed by atherosclerosis.

      Rhus coriaria L. (Rhus) with the public name of &quot;Somagh&quot; is a plant species in the
      anacardiaceae family that is used as a food supplement, spice in Middle East region (Iran,
      Turkey and Arabic countries).

      In a double blind randomized placebo-controlled clinical trial, the investigators want to
      evaluate the effects of Somagh (Rhus coriaria L.) on serum lipid levels of patients with
      hyperlipidemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rhus (Somagh) is found in temperate and tropical regions worldwide, often growing in areas of
      marginal agricultural capacity. Rhus is used as an herbal remedy in traditional medicine
      because of its assumed analgesic, antidiarrhetic, antiseptic, anorexic and antihypergylcemic
      properties. The fruits of Rhus contain flavonols, phenolic acids, hydrolysable tannins,
      anthocyans and organic acids such as malice, citric and tartaric acids. Some studies have
      shown that polyphenols could have beneficial effects on cardiovascular disease and cancer and
      could be regarded as bioactive compounds with a high potential health-promoting capacity.
      Phenolic compounds inhibit lipid peroxidation, scavenge the superoxide anion and hydroxyl
      radical, and enhance the activities of detoxifying enzymes.Moreover, the hypocholesterolemic
      action of dietary polyphenols has been reported. The hypocholesterolemic effect of Rhus fruit
      powder and its components have been reported previously in rabbits and mice.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum total cholesterol level</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum triglyceride level</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum HDL-cholesterol level</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum LDL-cholesterol level</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting Blood Sugar (FBS)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum creatinin level</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum ALT level</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum AST level</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum alkaline phosphatase level</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Hyperlipidemias</condition>
  <arm_group>
    <arm_group_label>Rhus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>500 mg of Rhus Coriaria L. (Rhus) powder in capsule: 1 capsule twice daily for 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsule: 1 capsule twice daily for 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rhus Coriaria L. (Rhus)</intervention_name>
    <description>500 mg of Rhus Coriaria L. (Rhus) powder in capsule: 1 capsule twice daily for 6 weeks</description>
    <arm_group_label>Rhus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo capsule: 1 capsule twice daily for 6 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 20-65 years

          -  Serum triglyceride &gt;150mg/dl AND/OR total cholesterol &gt;= 240mg/dl

        Exclusion Criteria:

          -  Serum triglyceride &gt; 500 mg/dl

          -  Serum LDL-cholesterol at level which need drug treatment according to the patient risk
             categories (NCEP-ATP III)

          -  Diabetes mellitus

          -  Hypo. or hyperthyroidism

          -  Any systemic illnesses e.g. liver cirrhosis, acute or chronic renal failure, heart
             failure

          -  Use of drugs: OCPs, lipid lowering agents, thiazides

          -  Pregnancy

          -  Alcoholism

          -  History of allergic reaction to Somagh
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mesbah Shams, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Majid Nimruzi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Traditional Medicine &amp; History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pooya Faridi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Traditional Medicine &amp; History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mojtaba Heydari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Traditional Medicine &amp; History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shahid Motahhari Clinic, Shiraz University of Medical Sciences</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2014</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>June 4, 2016</last_update_submitted>
  <last_update_submitted_qc>June 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shiraz University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Mesbah Shams, MD</investigator_full_name>
    <investigator_title>Associate professor of Internal Medicine &amp; Endocrinology</investigator_title>
  </responsible_party>
  <keyword>Rhus</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>Triglycerides</keyword>
  <keyword>Lipids</keyword>
  <keyword>Medicine, Traditional</keyword>
  <keyword>Herbal medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

